PECAM1 and neoplasm: Immunohistochemical analysis of bone metastases with an anti-CD31 antibody that specifically recognizes murine endothelial cells showed that a single treatment with ZOL or a daily treatment with US did not inhibit tumor-associated angiogenesis, compared with vehicle (Fig. 3a).